1. Corporate Officers - P
2. Petree Daniel H

Insider Trading History of Petree Daniel H

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Petree Daniel H since 2014. This trader's CIK number is 1294939. At the time of last reporting, Petree Daniel H was the Director of Sutro Biopharma, Inc.. (stock ticker symbol STRO). Also see all insider trading activities at Sutro Biopharma, Inc..

Note that in the past Petree Daniel H also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Sutro Biopharma, Inc. (STRO) by Petree Daniel H

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2022	STRO	0	$0	0	$0	14,277	$76,053
2021	STRO	0	$0	0	$0	4,132	$18,015
2019	STRO	0	$0	0	$0	826	$4,204
2018	STRO	0	$0	122	$1,830	314	$1,824

Yearly summary of insider trading at Apollo Endosurgery, Inc. (LPTN) by Petree Daniel H

		Insider Buying		Insider Sales		Option Exercises
Year	Symbol	Shares	Value	Shares	Value	Shares	Value
2016	LPTN	0	$0	0	$0	4,646	$0
2015	LPTN	0	$0	0	$0	6,509	$0
2014	LPTN	10,000	$27,830	0	$0	3,286	$0

Insider trading activities at 2 companies by Petree Daniel H:

1. Sutro Biopharma, Inc. (STRO)

2. Apollo Endosurgery, Inc. (LPTN)

Table 1. Insider trading of Sutro Biopharma, Inc. (STRO) by Petree Daniel H

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2022-02-08	STRO	Option Ex	14,277	5.33	76,053
2021-01-26	STRO	Option Ex	4,132	4.36	18,015
2019-09-06	STRO	Option Ex	826	5.09	4,204
2018-10-01	STRO	Option Ex	314	5.81	1,824
2018-10-01	STRO	Sale	122	15.00	1,830

Table 2. Insider trading of Apollo Endosurgery, Inc. (LPTN) by Petree Daniel H

Trade Date	Symbol	Trade Type	Shares	Price ($)	Value ($)
2016-03-09	LPTN	Option Ex	4,646	.00	0
2015-09-09	LPTN	Option Ex	794	.00	0
2015-04-22	LPTN	Option Ex	5,715	.00	0
2014-12-12	LPTN	Buy	10,000	2.78	27,830
2014-02-10	LPTN	Option Ex	3,286	.00	0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Petree Daniel H (Director of Sutro Biopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month